Cyclacel Pharmaceuticals (NASDAQ:CYCC) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Price Performance Cyclacel Pharmaceuticals stock opened at $0.25 on Friday. The firm has a market capitalization of $52.08 million, a P/E ratio of […]
StockNews.com started coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Price Performance Cyclacel Pharmaceuticals stock opened at $0.25 on Friday. The firm has a market capitalization of $52.08 million, a P/E ratio of […]
